NGM120, a GFRAL antagonist antibody, for investigation of safety, tolerability, and efficacy in hyperemesis gravidarum
Reproduction Abstracts · 06.06.2025
DOI: 10.1530/repabs.4.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction Abstracts, online erschienen am 06.06.2025. Verfasst von Joanne Sloan-Lancaster und 18 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sloan-Lancaster, J., Zhou, K., Henschel, C., Jeffry, U., Hanes, V., Melchor-Khan, L., Wu, K., Byrnes-Blake, K., Palumbo, A., Matharu, Z., Scherr, M., Fan, B., Kutach, A., Dai, Z., Wong, L., Ventura, R., Bojkovic, J., Hsu, A., & Lieu, H. D. (2025). NGM120, a GFRAL antagonist antibody, for investigation of safety, tolerability, and efficacy in hyperemesis gravidarum. Reproduction Abstracts. https://doi.org/10.1530/repabs.4.008
Vancouver
Sloan-Lancaster J, Zhou K, Henschel C, Jeffry U, Hanes V, Melchor-Khan L, et al. NGM120, a GFRAL antagonist antibody, for investigation of safety, tolerability, and efficacy in hyperemesis gravidarum. Reproduction Abstracts. 2025. doi:10.1530/repabs.4.008
BibTeX
@article{SloanLancaster2025,
author = {Sloan-Lancaster, Joanne and Zhou, Kefei and Henschel, Carroll and Jeffry, Ursula and Hanes, Vladimir and Melchor-Khan, Liza and Wu, Katherine and Byrnes-Blake, Kelly and Palumbo, Alessandro and Matharu, Zimple and Scherr, Matthias and Fan, Bin and Kutach, Alan and Dai, Zhefu and Wong, Leanne and Ventura, Richard and Bojkovic, Jade and Hsu, Arthur and Lieu, Hsiao D.},
title = {NGM120, a GFRAL antagonist antibody, for investigation of safety, tolerability, and efficacy in hyperemesis gravidarum},
journal = {Reproduction Abstracts},
year = {2025},
doi = {10.1530/repabs.4.008}
}
EUVIMED